IP Library Granted Patent US 9,149,529
Granted Patent B2
US 9,149,529 · App. 13/794,421 · Granted Oct 6, 2015

Stable compositions containing thrombin and methods for preparation and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,149,529
App. No.
13/794,421
Granted
Oct 6, 2015
Kind
B2
Abstract

Compositions comprising thrombin and collagen and methods of preparation thereof are disclosed herein. In one embodiment, a composition comprises thrombin and collagen in an aqueous buffer solution, wherein the buffer solution includes at least one of a first compound represented by Formula I: R 1 —C(O)—O − M + , wherein R 1 is —CH 3 , —CH 2 CH 2 C(O)OH, or —CH 2 CH 2 C(O)O − M + , and wherein M + is a monovalent ion; or a second compound represented by Formula II: R 2 —C(O)—O − M 2+− O—C(O)—R 2 , wherein R 2 is —CH 3 or —CH 2 CH 3 , and wherein M 2+ is a divalent ion. In one embodiment, the buffer solution includes sodium acetate, calcium propionate, and sorbitol.

Claims (24)

1. A composition comprising thrombin and pepsinized microfibrillar collagen in an aqueous buffer solution, wherein the buffer solution includes:

at least one sugar selected from the group consisting of mannitol, sorbitol, sucrose, raffinose, and trehalose; and at least one of a first compound or a second compound,

wherein the first compound is represented by the following Formula I:

wherein R 1 is —CH 3 , —CH 2 CH 2 C(O)OH, or —CH 2 CH 2 C(O)O M + , and wherein M + is a monovalent ion, and

wherein the second compound is represented by the following Formula II:

wherein R 2 is —CH 3 or —CH 2 CH 3 , and wherein M 2+ is a divalent ion, and

wherein the buffer solution does not include a chloride-containing salt.

2. The composition of claim 1 , where the thrombin is bovine thrombin.

3. The composition of claim 1 , wherein the thrombin is recombinant thrombin.

4. The composition of claim 1 , wherein M + is a sodium ion (Na + ).

5. The composition of claim 4 , wherein R 1 is —CH 3 .

6. The composition of claim 4 , wherein R 1 is —CH 2 CH 2 C(O)O − M + .

7. The composition of claim 1 , wherein M 2+ is a calcium ion (Ca 2+ ).

8. The composition of claim 7 , wherein R 2 is —CH 3 .

9. The composition of claim 7 , wherein R 2 is —CH 2 CH 3 .

10. The composition of claim 1 , wherein the pH of the composition ranges from about 5.5 to about 6.5.

11. The composition of claim 1 , wherein an initial thrombin activity ranges from about 400 to about 500 units of enzyme activity per milliliter of buffer solution.

12. The composition of claim 11 , wherein M+ is a sodium ion (Na + ), R 1 is —CH 3 , M 2+ is a calcium ion (Ca 2+ ) and R 2 is —CH 2 CH 3 , and wherein the buffer solution further comprises sorbitol.

13. The composition of claim 1 , wherein the buffer solution includes the second compound, and further comprises sorbitol.

14. The composition of claim 1 , wherein the buffer solution includes sodium acetate, calcium propionate, and sorbitol.

15. The composition of claim 1 , wherein the buffer solution includes sodium succinate, calcium propionate, and sorbitol.

16. The composition of claim 15 , wherein the sodium succinate is dibasic.

17. The composition of claim 1 , wherein the buffer solution include calcium acetate and sorbitol.

18. The composition of claim 1 , wherein the buffer solution includes calcium acetate and mannitol.

Assignments (3)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: ORTHOVITA, INC.
To: STRYKER CORPORATION
Reel/Frame 065735/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2013
From: GARIGAPATI, VENKAT R.
To: ORTHOVITA, INC.
Reel/Frame 030343/0836 →